Patent ID: 11939578
Assignee: BEIJING TIDE PHARMACEUTICAL CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 6:
7. The pharmaceutical composition of claim 6, wherein the modified nucleotide is selected from the group consisting of: 2′-O-methyl modified nucleotides, 2′-F modified nucleotides, nucleotides containing 5′-phosphorothioate groups and end nucleotides linked to cholesteryl derivatives or dodecanoic acid bisdecylamide groups, 2′-deoxy-2′-fluoro modified nucleotides, 2′-deoxy-modified nucleotides, locked nucleotides, abasic nucleotides, 2′-amino-modified nucleotides, 2′-alkyl-modified nucleotides, morpholino nucleotides, phosphoramidates and nucleotides containing non-natural bases.